Potassium Carbonate → (3R)-3-ethyl-1-(2-((2-methyl-1,3-thiazol-5-yl)amino)pyrimidin-4-yl)-2-oxopyrrolidine-3-carbonitrile hydrochloride

HRID 714888노트

반응식

HRID 714888 반응식
[Cl:1][C:2]1[N:7]=[C:6]([N:8]2[CH2:12][CH2:11][C@:10]([CH2:15][CH3:16])([C:13]#[N:14])[C:9]2=[O:17])[CH:5]=[CH:4][N:3]=1.[CH3:18][C:19]1[S:20][C:21]([NH2:24])=[CH:22][N:23]=1.C(=O)([O-])[O-].[K+].[K+].C1(P(C2CCCCC2)C2C=CC=CC=2C2C(C(C)C)=CC(C(C)C)=CC=2C(C)C)CCCCC1>C(O)(C)(C)C.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[ClH:1].[CH2:15]([C@:10]1([C:13]#[N:14])[CH2:11][CH2:12][N:8]([C:6]2[CH:5]=[CH:4][N:3]=[C:2]([NH:24][C:21]3[S:20][C:19]([CH3:18])=[N:23][CH:22]=3)[N:7]=2)[C:9]1=[O:17])[CH3:16]

참가 물질

7

반응물 4

HCID 11430Potassium CarbonateHCID 111557942-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 208298802-Methyl-1,3-thiazol-5-amineHCID 117840665(3R)-1-(2-chloropyrimidin-4-yl)-3-ethyl-2-oxopyrrolidine-3-carbonitrile

생성물 1

HCID 117840893(3R)-3-ethyl-1-(2-((2-methyl-1,3-thiazol-5-yl)amino)pyrimidin-4-yl)-2-oxopyrrolidine-3-carbonitrile hydrochloride수율 10.3%

시약·촉매·용매 2

HCID 9811564Bis(dibenzylideneacetone)palladium촉매HCID 6386tert-Butanol용매

실험 절차

To a mixture of (3R)-1-(2-chloropyrimidin-4-yl)-3-ethyl-2-oxopyrrolidine-3-carbonitrile (100 mg) obtained in Step A of Example 8, 2-methyl-1,3-thiazol-5-amine (56 mg), potassium carbonate (110 mg) and dicyclohexyl(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine (58 mg) in tert-butanol (1.0 mL) was added tris(dibenzylideneacetone)dipalladium(0) (22 mg), and the mixture was stirred for 5 hr with heated under reflux. The insoluble substance was removed by filtration through Celite, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate). To a solution of the obtained compound (26 mg) in ethanol (2.0 mL) was added 1 M hydrochloric acid (80 μL), and the mixture was stirred at room temperature for 5 min. The solvent was evaporated under reduced pressure, and the residue was recrystallized (ethanol) to give the title compound (15 mg).

후처리

  1. temperaturewith heated
  2. temperatureunder reflux
  3. customThe insoluble substance was removed by filtration through Celite
  4. customthe solvent was evaporated under reduced pressure
  5. customThe residue was purified by silica gel column chromatography (hexane/ethyl acetate)
  6. additionTo a solution of the obtained compound (26 mg) in ethanol (2.0 mL) was added 1 M hydrochloric acid (80 μL)
  7. stirringthe mixture was stirred at room temperature for 5 min
  8. customThe solvent was evaporated under reduced pressure
  9. customthe residue was recrystallized (ethanol)

출처 및 근거

ORD 기록
ord-1d052eeb7c8e491db6e905342eba5eea
출처 데이터셋
uspto-grants-2015_11
특허 번호
US09187453B2

반응 노트

불러오는 중…